ImmuCell Corporation (ICCC)
NASDAQ: ICCC · Real-Time Price · USD
10.00
0.00 (0.00%)
Sep 3, 2026, 4:00 PM EDT - Market closed
ImmuCell Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 91 | 56 | 46 | 39 | 47 | 62 | |
Market Cap Growth | 62.46% | 21.22% | 16.33% | -16.51% | -23.70% | 44.31% |
Enterprise Value | 94 | 65 | 58 | 54 | 51 | 62 |
Last Close Price | 10.00 | 6.15 | 5.15 | 5.09 | 6.10 | 8.00 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PS Ratio | 2.96 | 2.01 | 1.73 | 2.26 | 2.55 | 3.22 |
PB Ratio | 2.89 | 2.06 | 1.67 | 1.58 | 1.56 | 1.90 |
P/TBV Ratio | 2.90 | 2.06 | 1.68 | 1.59 | 1.56 | 1.91 |
P/FCF Ratio | 21.55 | 45.42 | - | - | - | - |
P/OCF Ratio | 15.41 | 22.48 | 128.23 | - | - | 64.91 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 3.08 | 2.36 | 2.17 | 3.10 | 2.76 | 3.22 |
EV/EBITDA Ratio | 13.39 | 12.62 | 55.03 | - | 65.78 | 22.78 |
EV/EBIT Ratio | 20.23 | 26.68 | - | - | - | 240.62 |
EV/FCF Ratio | 22.40 | 53.36 | - | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.40 | 0.49 | 0.55 | 0.67 | 0.41 | 0.32 |
Debt / EBITDA Ratio | 1.66 | 2.33 | 9.80 | - | 12.96 | 3.57 |
Debt / FCF Ratio | 2.95 | 10.77 | - | - | - | - |
Net Debt / Equity Ratio | 0.11 | 0.35 | 0.41 | 0.63 | 0.22 | 0.00 |
Net Debt / EBITDA Ratio | 0.51 | 1.81 | 10.83 | -6.27 | 8.60 | 0.03 |
Net Debt / FCF Ratio | 0.85 | 7.66 | -105.19 | -2.39 | -1.21 | -0.05 |
Asset Turnover | 0.66 | 0.63 | 0.60 | 0.39 | 0.42 | 0.45 |
Inventory Turnover | 2.11 | 1.98 | 2.49 | 1.89 | 2.26 | 4.09 |
Quick Ratio | 2.65 | 1.82 | 1.72 | 0.76 | 2.47 | 5.09 |
Current Ratio | 4.75 | 4.26 | 3.41 | 2.73 | 4.56 | 6.42 |
Return on Equity (ROE) | 2.57% | -3.81% | -8.21% | -20.86% | -7.92% | -0.26% |
Return on Assets (ROA) | 6.25% | 3.49% | -2.31% | -7.36% | -2.39% | 0.38% |
Return on Invested Capital (ROIC) | 12.29% | 6.50% | -4.12% | -13.43% | -4.90% | 0.81% |
Return on Capital Employed (ROCE) | 11.10% | 6.40% | -4.00% | -13.20% | -4.10% | 0.60% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 0.87% | -1.87% | -4.70% | -14.64% | -5.28% | -0.13% |
FCF Yield | 4.64% | 2.20% | -0.24% | -16.64% | -11.68% | -2.67% |
Buyback Yield / Dilution | -3.49% | -10.52% | -5.42% | -0.03% | -2.01% | -5.25% |